A failed trial for a heart drug casts shadow over rivals developing similar therapies
Source MarketWatch 财经4h ago
Summary
The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.
We index headlines and summaries only. Full content and copyright remain with the original publisher — follow the source link to read it.
Open original- Desk
- Business
- Region
- Americas
- Language
- English
- Item ID
- business-c3b1dbbd
Comments 0 comments
No comments yet. Be the first.